期刊文献+

47例氯胺酮滥用者临床分析 被引量:1

The Clinical analysis of 47 Ketamine abusers cases
原文传递
导出
摘要 目的:探讨氯胺酮(K粉)滥用的临床特点、维持滥用的因素和疗效等。方法:对本院2014年5月至2015年6月单独滥用氯胺酮的47例住院患者临床资料进行临床分析。结果:患者男性为主,普遍文化程度高中或中专以下(87.2%),无业或个体经营占89.4%。滥用氯胺酮诱因与维持滥用因素主要有同伴、烦恼、渴求等。临床表现为情感障碍、泌尿系统相关损害为主要临床相。患者精神症状消失时间在8-56天,平均(24.8±10.1)天。临床治愈24(51.1%),显著进步19例(40.4%),显效率91.5%,好转4例(8.5%)。结论:滥用氯胺酮诱因与继续滥用因素主要为同伴、烦恼和渴求。临床主要表现为精神症状、泌尿系统相关损害。药物治疗重点以处理精神症状、泌尿系统相关损害为主,兼顾心理治疗,疗效较好。 Objective: To study the the Ketamine's clinical characters、the factors of maintenance and the Medication. Methods:Analyzing the clinical data of 47 patients,from May 2014 to June 2015,hospitalized with ketamine dependence in our hospital.Results: It's the male patient dominated,the general level of education is high school or below the technical secondary( 87. 2%),no busniness or individual business accounting for 89. 4%. The main factors of the abuse and maintenance of "K"Powder are companions,annoyances and carving,etc. The clinical manifestations are emotional disorders and the main clinical phase is the urinary system damage. Psychiatric symptoms disappered in 8-56 days. the average is in( 24. 8 ± 10. 1) days. There are 24 clinical cure cases( 51. 1%) and 19 marked improvement cases( 8. 5%). The effective rate is 91. 5%. Conclusion: The main factors of the abuse and maintenance of "K"Powder are companions,annoyances and carving. The main clinical manifestations are psychosis and urinary system damage. Drug treament focuses on the treament of psychosis,urinary system damage,supplementing with the psychological treatment. The effect is better.
出处 《中国药物滥用防治杂志》 CAS 2016年第4期198-200,204,共4页 Chinese Journal of Drug Abuse Prevention and Treatment
关键词 氯胺酮滥用 临床特点 维持滥用因素 疗效 Ketamine abuse clinical characteristics maintaining abuse factors effect
  • 相关文献

参考文献7

二级参考文献49

  • 1连智,刘志民,刘锐克,孙桂宽,穆悦,吕宪祥,曹家琪.我国部分地区氯胺酮滥用流行病学调查[J].中国药物依赖性杂志,2005,14(4):280-283. 被引量:42
  • 2丘志馨.氯胺酮的药理作用及滥用问题探讨[J].广东公安科技,2006,14(1):14-18. 被引量:15
  • 3蔡志基.全球药物滥用现状与主要动向[A]..第一届药物滥用流行病学研讨会论文汇编[C].,1998.1-8.
  • 4刘志民.全球毒品与艾滋病形式.吸毒与艾滋病降低危害资讯,2006,1:1-2
  • 52006年中国禁毒报告,中华人民共和国国家禁毒委员办公室
  • 6Hegadoren KM.Baker GB,Bourin M.3,4-Methylene dioxy analogues of amphetamine:defining the risks to humans.Neurosci Biobehav Rev,1999,23:539-553
  • 7Hao W,Monteiro M.Global situation on ecstasy.Pre senting in WHO Meeting on ATS and MDMA,1999,Bangkok,Thailand
  • 8Miller NS.Amphetamines.In:Miller N,ed.Com prehensive handbook of drug and alcohol addiction,New York:Dekker 1991.427-436
  • 9.《苯丙胺类兴奋剂滥用及其相关障碍的诊断治疗指导原则》.中华人民共和国卫生部国家药品监督管理局,2002.2-3.
  • 10Lenton S,Boys A,Norcross K.Raves,drugs and experience:drug use by a sample of people who at tend raves in Western Australia.Addiction,1997,92(10):1327-1337

共引文献129

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部